Insights on the Angioedema Treatment Global Market Research Report to 2027 - Players Include BioCryst Pharmaceuticals, Cipla USA and CSL Behring - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Angioedema Treatment Market Research Report by Drugs Type, Route of Administration, End-User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The Global Angioedema Treatment Market size was estimated at USD 3,425.93 million in 2021, USD 4,008.36 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 17.17% to reach USD 8,868.50 million by 2027.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Angioedema Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Angioedema Treatment Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Angioedema Treatment Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Angioedema Treatment Market?

4. What is the competitive strategic window for opportunities in the Global Angioedema Treatment Market?

5. What are the technology trends and regulatory frameworks in the Global Angioedema Treatment Market?

6. What is the market share of the leading vendors in the Global Angioedema Treatment Market?

7. What modes and strategic moves are considered suitable for entering the Global Angioedema Treatment Market?

Market Dynamics

Drivers

• Increasing cases of hereditary angioedema (HAE) globally
• Growing initiatives for improving awareness levels among the population
• Rising incidence of genetic mutation leading to disorder

Restraints

• Misdiagnosis of angioedema

Opportunities

• Large population with unmet medical needs
• New therapies & innovations in angioedema treatment

Challenges

• High cost of the drugs used for treatment

Companies Mentioned

• Adverum Biotechnologies, Inc.
• AMBOSS
• Apotex Corp.
• AstraZeneca PLC
• Attune Pharmaceuticals, Inc.
• BioCryst Pharmaceuticals, Inc.
• Cipla USA Inc.
• CSL Behring GmbH
• Dyax Corp.
• Fresenius Kabi USA, LLC
• GlaxoSmithKline PLC
• Ionis Pharmaceuticals, Inc.
• KalVista Pharmaceuticals, Inc.
• Lecturio GmbH
• Merck & Co., Inc.
• Pharming Group N.V.
• Sanofi S.A
• Shire Pharmaceuticals Ireland Limited
• Slayback Pharma LLC
• Takeda Pharmaceutical Company Limited
• Teva Pharmaceuticals USA, Inc.
• Viropharma Biologics Llc

For more information about this report visit https://www.researchandmarkets.com/r/rbi8j3

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900